{"organizations": [], "uuid": "b201a6051989d68402997893093c7a30babb10cb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/6", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/22/globe-newswire-emerald-health-therapeutics-to-present-at-upcoming-investor-conferences.html", "country": "US", "domain_rank": 767, "title": "Emerald Health Therapeutics to Present at Upcoming Investor Conferences", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-22T16:00:00.000+03:00", "replies_count": 0, "uuid": "b201a6051989d68402997893093c7a30babb10cb"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/22/globe-newswire-emerald-health-therapeutics-to-present-at-upcoming-investor-conferences.html", "ord_in_thread": 0, "title": "Emerald Health Therapeutics to Present at Upcoming Investor Conferences", "locations": [], "entities": {"persons": [{"name": "avtar dhillon", "sentiment": "none"}, {"name": "ritz-carlton toronto webcast", "sentiment": "none"}, {"name": "chris wagner", "sentiment": "none"}], "locations": [{"name": "victoria", "sentiment": "none"}, {"name": "british columbia", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}, {"name": "frankfurt", "sentiment": "none"}, {"name": "bel air", "sentiment": "none"}], "organizations": [{"name": "emerald health therapeutics", "sentiment": "negative"}, {"name": "emerald health therapeutics, inc.", "sentiment": "neutral"}, {"name": "village farms international, inc.", "sentiment": "none"}, {"name": "about emerald health therapeutics, inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "VICTORIA, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) today announced that members of its executive team will present at upcoming investor conferences.\nBMO Capital Market’s Inaugural Cannabis Conference\nDate: Wednesday, May 30, 2018\nPresenter: Dr. Avtar Dhillon, Executive Chairman\nTime: 9:10 am ET\nLocation: Ritz-Carlton Toronto\nWebcast: https://bit.ly/2kdJDQX\nLD Micro 8 th Invitational\nDate: Monday, June 4, 2018\nPresenter: Chris Wagner, CEO\nTime: 11:00 am PT\nLocation: Luxe Sunset Boulevard Hotel, Bel Air, CA\nWebcast: https://bit.ly/2IY5Znp\nA replay of both presentations will be archived for 90 days following the conclusion of the event.\nAbout Emerald Health Therapeutics, Inc.\nEmerald Health Therapeutics (TSXV:EMH) (OTCQX:EMHTF) (Frankfurt:TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50% of a joint venture with Village Farms International, Inc. that is converting an existing 1.1 million square foot greenhouse in Delta, BC to grow cannabis. It owns a 75,000 square foot indoor facility in St. Eustache, QC and is adding a 500,000 square foot greenhouse in Metro Vancouver to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald’s team is highly experienced in life sciences, product development and large-scale agribusiness. Emerald Health Therapeutics is part of the Emerald Health group , which includes multiple companies focused on developing cannabis and cannabinoid products with potential wellness and medical benefits.\nPlease visit www.emeraldhealth.ca for more information or contact:\nRob Hill, Chief Financial Officer\n(800) 757 3536 Ext. #5\nRay Lagace, Investor Relations Manager\n(800) 757 3536 Ext. #5\ninvest@emerald.care\nCautionary Statements Regarding Forward Looking Information\nCertain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are \"forward-looking statements\".\nWe caution you that such \"forward-looking statements\" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, the filing and effectiveness of the prospectus supplement; the use of proceeds from the Offering; the anticipated closing date of the Offering and the Secondary Sale; the development, expansion and conversion of greenhouse facilities; and the starting of adult-use cannabis market in 2018.\nEmerald Health Therapeutics Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, failure to meet the conditions of closing of the Offering; uncertainty with respect to the completion of the Offering; filing of the shelf prospectus supplement; the ability to obtain applicable regulatory approval for the Offering and the Secondary Sale; the ability of the Company to negotiate and complete future funding transactions; variations in market conditions; and other risk factors described in the Prospectus and the Company's other filings with the applicable Canadian securities regulators, which may be viewed at www.sedar.com. Actual results may differ materially from those expressed or implied by such forward-looking statements.\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.\nSource: Emerald Health Therapeutics Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=MB3q4YWw0eMM9BLps97R9RJg-RMivOxC7KNBylFzOZKpBKFc_Am8QGx9CBQIrI6CJV-U_-vwZ6uez51WMOcefRDcmIUa7KSvQ82xtwTlbUI=", "https://www.globenewswire.com/Tracker?data=kUEGDIbP3yBWY99ljRShaDoTCJjvF6a3yaKC6r5_yPR1iMfkPscqFTQongktpmTBEsp9Dd_s9Mj5-DxJIONQP6LD9P6e3wk7qZK4xim448U=", "https://www.globenewswire.com/Tracker?data=gntZRKnjzsPlpO4003jUh6rwDPEj9QvfYslXMx-6tibfAlMpNXKnfdc76BXXQevu97L4_ayZ267oQtwiyheIBw==", "https://www.globenewswire.com/Tracker?data=IZDW0IzhXq8pUXauK8HEPq4XYkU0BWRWH1pEdAp_Iuy8Ml4lcc9pO0uBVcL9clysmB4L48c2FvVEhn1ZuUWCOMy6tzJ_8ogBJf0XOtNmOkU=", "https://www.globenewswire.com/Tracker?data=qjQp3KTS7PdY54IBmC-akRIUw_bBnW0vwqalGwyBLYwPOJi00oygfhC5FyTop9StqNeBxKf-LnJmw5wJwABYKJt-0OlOe-sKR7AVSLvgQtA=", "https://bit.ly/2kdJDQX", "https://www.globenewswire.com/Tracker?data=7aJ2-MAK0cKnc0DEmcWkGclEmX_NfuDtsgUodTOT6n-eoo-yMEmGKNdLt6aYITydobLDiXaTkJ8aooQUPJwFI4kWBtyS8XtCBKchtMKv9Jo=", "https://www.globenewswire.com/Tracker?data=kUEGDIbP3yBWY99ljRShaBdkruWspua83zi551LkljFCwH7HAqAwZ2u78xDCT-hBPeXSncGRpTJK3sUVGfYwy-jzEqXzzClbUj_6WtUCWRc=", "https://bit.ly/2IY5Znp", "https://www.globenewswire.com/NewsRoom/AttachmentNg/bc102817-e4d7-42c4-ba4c-b88a9aa9955d"], "published": "2018-05-22T16:00:00.000+03:00", "crawled": "2018-05-22T18:05:57.005+03:00", "highlightTitle": ""}